{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:51:16Z","timestamp":1792461076127,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930081"],"award-info":[{"award-number":["81930081"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92159303"],"award-info":[{"award-number":["92159303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82488101"],"award-info":[{"award-number":["82488101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330056"],"award-info":[{"award-number":["82330056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2024B01J1154"],"award-info":[{"award-number":["2024B01J1154"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Department of Science and Technology of Guangdong Province","doi-asserted-by":"publisher","award":["2023B1212060013"],"award-info":[{"award-number":["2023B1212060013"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["20212200003"],"award-info":[{"award-number":["20212200003"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011785","name":"Science and Technology Department of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1300602"],"award-info":[{"award-number":["2021YFA1300602"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.it.2025.01.002","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:05:16Z","timestamp":1737936316000},"page":"121-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The \u2018inflammazone\u2019 in chronic inflammatory diseases: psoriasis and sarcoidosis"],"prefix":"10.1016","volume":"46","author":[{"given":"Phei Er","family":"Saw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2025.01.002_bb0005","first-page":"24","article-title":"Cells and cytokines involved in the pathogenesis of sarcoidosis","volume":"16","author":"Moller","year":"1999","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.it.2025.01.002_bb0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrrheum.2011.93","article-title":"Sarcoidosis \u2013 scientific progress and clinical challenges","volume":"7","author":"Chen","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.it.2025.01.002_bb0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0020","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.649408","article-title":"Cutaneous and systemic psoriasis: classifications and classification for the distinction","volume":"8","author":"Yan","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00002281-200001000-00012","article-title":"New pathogenetic insights into the sarcoid granuloma","volume":"12","author":"Agostini","year":"2000","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.it.2025.01.002_bb0035","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s13238-021-00839-6","article-title":"Higher-order assemblies in immune signaling: supramolecular complexes and phase separation","volume":"12","author":"Xia","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.it.2025.01.002_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.986589","article-title":"Phase separation drives the formation of biomolecular condensates in the immune system","volume":"13","author":"Wen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.it.2025.01.002_bb0050","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1286-4579(99)00250-6","article-title":"TGF-beta and fibrosis","volume":"1","author":"Branton","year":"1999","journal-title":"Microbes Infect."},{"key":"10.1016\/j.it.2025.01.002_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2017.12.012","article-title":"Th17-lineage cells in pulmonary sarcoidosis and L\u00f6fgren's syndrome: friend or foe?","volume":"87","author":"Miedema","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.it.2025.01.002_bb0060","article-title":"The circulating Treg\/Th17 cell ratio is correlated with relapse and treatment response in pulmonary sarcoidosis patients after corticosteroid withdrawal","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2025.01.002_bb0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/jaut.1999.0343","article-title":"CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry","volume":"14","author":"Ferenczi","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.it.2025.01.002_bb0070","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2133.2004.05863.x","article-title":"Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late","volume":"150","author":"Vissers","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0075","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1046\/j.1365-2133.2001.04222.x","article-title":"Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis","volume":"144","author":"Yawalkar","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0080","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.01.002_bb0085","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/sj.jid.5700310","article-title":"Prominent production of IL-20 by CD68+\/CD11c+ myeloid-derived cells in psoriasis: gene regulation and cellular effects","volume":"126","author":"Wang","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1172\/JCI117308","article-title":"Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines","volume":"94","author":"Nestle","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2025.01.002_bb0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris","volume":"199","author":"Lee","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0100","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1189\/jlb.0307133","article-title":"Expression and role of CCR6\/CCL20 chemokine axis in pulmonary sarcoidosis","volume":"82","author":"Facco","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.it.2025.01.002_bb0105","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.3390\/jcm10132857","article-title":"A primer on the clinical aspects of sarcoidosis for the basic and translational scientist","volume":"10","author":"Judson","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0110","article-title":"Cutaneous sarcoidosis: clinical and pathologic features, molecular pathogenesis, and treatment","author":"Damsky","year":"2024","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0115","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3389\/fimmu.2020.01719","article-title":"Current sarcoidosis models and the importance of focusing on the granuloma","volume":"11","author":"Locke","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0120","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCRESAHA.121.320449","article-title":"Transcriptional and immune landscape of cardiac sarcoidosis","volume":"131","author":"Liu","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.it.2025.01.002_bb0125","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ajpath.2010.11.065","article-title":"M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis","volume":"178","author":"Prokop","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.it.2025.01.002_bb0130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40744-020-00221-8","article-title":"Disease characteristics and the burden of joint and skin involvement amongst people with psoriatic arthritis: a population survey","volume":"7","author":"Tillett","year":"2020","journal-title":"Rheumatol. Ther."},{"key":"10.1016\/j.it.2025.01.002_bb0135","doi-asserted-by":"crossref","first-page":"15328","DOI":"10.1038\/s41598-020-72067-7","article-title":"Sarcoidosis exosomes stimulate monocytes to produce pro-inflammatory cytokines and CCL2","volume":"10","author":"Wahlund","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.it.2025.01.002_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4062\/biomolther.2020.054","article-title":"The role of leptin in the association between obesity and psoriasis","volume":"29","author":"Hwang","year":"2021","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.it.2025.01.002_bb0145","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1798606","article-title":"Dendritic cells release exosomes together with phagocytosed pathogen; potential implications for the role of exosomes in antigen presentation","volume":"9","author":"Lindenbergh","year":"2020","journal-title":"J. Extracell Vesicles"},{"key":"10.1016\/j.it.2025.01.002_bb0150","first-page":"1143","article-title":"Increased levels of interleukin-17A exosomes in psoriasis","volume":"99","author":"Jacquin-Porretaz","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.it.2025.01.002_bb0155","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s13054-021-03775-3","article-title":"Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury","volume":"25","author":"Jiao","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.it.2025.01.002_bb0160","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1096\/fj.201802090RR","article-title":"Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis via activating keratinocytes","volume":"33","author":"Shao","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.it.2025.01.002_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3623898","article-title":"Mast cell-derived exosomes promote Th2 cell differentiation via OX40L-OX40 ligation","volume":"2016","author":"Li","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.it.2025.01.002_bb0170","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1084\/jem.20160258","article-title":"Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a","volume":"213","author":"Cheung","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0175","doi-asserted-by":"crossref","first-page":"12732","DOI":"10.1021\/acsnano.0c03064","article-title":"Exosome-mediated crosstalk between keratinocytes and macrophages in cutaneous wound healing","volume":"14","author":"Zhou","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.it.2025.01.002_bb0180","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jid.2020.07.009","article-title":"Small extracellular vesicles containing miR-381-3p from keratinocytes promote T helper type 1 and T helper type 17 polarization in psoriasis","volume":"141","author":"Jiang","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0185","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bjd.21627","article-title":"Biomarkers of disease progression in people with psoriasis: a scoping review","volume":"187","author":"Ramessur","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0190","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.it.2024.04.013","article-title":"Sarcoidosis immunopathogenesis \u2013 a new concept of maladaptive trained immunity","volume":"45","author":"Robert","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0195","doi-asserted-by":"crossref","first-page":"11940","DOI":"10.3390\/ijms231911940","article-title":"Psoriasis, is it a microdamage of our \"sixth sense\"? A neurocentric view","volume":"23","author":"Sonkodi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.it.2025.01.002_bb0200","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171088","article-title":"Activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis","volume":"133","author":"Nakamizo","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2025.01.002_bb0205","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.4049\/jimmunol.1600258","article-title":"Dual Inhibition of Rip2 and IRAK1\/4 regulates IL-1beta and IL-6 in sarcoidosis alveolar macrophages and peripheral blood mononuclear cells","volume":"197","author":"Talreja","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.humimm.2017.10.009","article-title":"Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: a new aspect of macrophage heterogeneity","volume":"79","author":"Shamaei","year":"2018","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0220","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1165\/rcmb.2018-0053OC","article-title":"IL-13-regulated macrophage polarization during granuloma formation in an in vitro human sarcoidosis model","volume":"60","author":"Locke","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.it.2025.01.002_bb0225","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1067\/mai.2000.107604","article-title":"IL-4\/IL-13 signaling beyond JAK\/STAT","volume":"105","author":"Jiang","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0230","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1183\/09031936.00195010","article-title":"Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis","volume":"38","author":"Sahoo","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.it.2025.01.002_bb0235","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1074\/jbc.M113.535765","article-title":"Doxycycline inhibits polarization of macrophages to the proangiogenic M2-type and subsequent neovascularization","volume":"289","author":"He","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2025.01.002_bb0240","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1164\/rccm.201401-0188OC","article-title":"Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity","volume":"190","author":"Braun","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.it.2025.01.002_bb0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1165\/rcmb.2016-0037OC","article-title":"Programmed death-1 inhibition of phosphatidylinositol 3-kinase\/AKT\/mechanistic target of rapamycin signaling impairs sarcoidosis CD4(+) T cell proliferation","volume":"56","author":"Celada","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.it.2025.01.002_bb0250","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12931-015-0265-8","article-title":"Impaired survival of regulatory T cells in pulmonary sarcoidosis","volume":"16","author":"Broos","year":"2015","journal-title":"Respir. Res."},{"key":"10.1016\/j.it.2025.01.002_bb0255","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1164\/rccm.201503-0635LE","article-title":"Decreased cytotoxic T-lymphocyte antigen 4 expression on regulatory T cells and Th17 cells in sarcoidosis: double trouble?","volume":"192","author":"Broos","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.it.2025.01.002_bb0260","doi-asserted-by":"crossref","first-page":"1233514","DOI":"10.3389\/fimmu.2023.1233514","article-title":"Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide","volume":"14","author":"Lee","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0265","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/rccm.201206-1024OC","article-title":"Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis?","volume":"187","author":"Kamphuis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.it.2025.01.002_bb0270","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1128\/CVI.05118-11","article-title":"Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis","volume":"18","author":"Lee","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0275","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.192.10.1453","article-title":"BAFF mediates survival of peripheral immature B lymphocytes","volume":"192","author":"Batten","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0280","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/rheumatology\/ket186","article-title":"Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity","volume":"52","author":"Ueda-Hayakawa","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.it.2025.01.002_bb0285","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41581-020-00334-x","article-title":"Organ immune responses \u2014 don\u2019t forget the structural cells","volume":"16","author":"Tuong","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.it.2025.01.002_bb0290","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41586-020-2424-4","article-title":"Structural cells are key regulators of organ-specific immune responses","volume":"583","author":"Krausgruber","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.01.002_bb0295","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2023.01.014","article-title":"Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation","volume":"56","author":"Krausgruber","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.01.002_bb0300","doi-asserted-by":"crossref","first-page":"3s","DOI":"10.1177\/12034754221141680","article-title":"Clinical implications of targeting the JAK-STAT pathway in psoriatic disease: emphasis on the TYK2 pathway","volume":"27","author":"Loo","year":"2023","journal-title":"J. Cutan. Med. Surg."},{"key":"10.1016\/j.it.2025.01.002_bb0305","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MPA.0000000000000294","article-title":"Nicotine ameliorates experimental severe acute pancreatitis via enhancing immunoregulation of CD4+ CD25+ regulatory T cells","volume":"44","author":"Zheng","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.it.2025.01.002_bb0310","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1378\/chest.12-0383","article-title":"Nicotine treatment improves Toll-like receptor 2 and Toll-like receptor 9 responsiveness in active pulmonary sarcoidosis","volume":"143","author":"Julian","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.it.2025.01.002_bb0315","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaad.2022.03.059","article-title":"Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled study","volume":"87","author":"Tehlirian","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0320","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/art.42519","article-title":"Efficacy and safety of the TYK2\/JAK1 inhibitor brepocitinib for active psoriatic arthritis: a phase IIb randomized controlled trial","volume":"75","author":"Mease","year":"2023","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.it.2025.01.002_bb0325","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/jdv.19811","article-title":"Efficacy and safety of piclidenoson in plaque psoriasis: results from a randomized phase 3 clinical trial (COMFORT-1)","volume":"38","author":"Papp","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.it.2025.01.002_bb0330","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaad.2021.07.040","article-title":"Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial","volume":"86","author":"Stein Gold","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0335","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq3254","article-title":"Local IL-23 is required for proliferation and retention of skin-resident memory T(H)17 cells","volume":"7","author":"Whitley","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0340","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1056\/NEJMoa2308713","article-title":"An oral interleukin-23\u2013receptor antagonist peptide for plaque psoriasis","volume":"390","author":"Bissonnette","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0345","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03137-22","article-title":"Aryl hydrocarbon receptor activation ameliorates acute respiratory distress syndrome through regulation of Th17 and Th22 cells in the lungs","volume":"14","author":"Holloman","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.it.2025.01.002_bb0350","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","article-title":"The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease","volume":"19","author":"Rothhammer","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0355","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40257-021-00641-4","article-title":"Tapinarof cream 1% for extensive plaque psoriasis: a maximal use trial on safety, tolerability, and pharmacokinetics","volume":"23","author":"Jett","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0360","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/1346-8138.17423","article-title":"Tapinarof cream for the treatment of plaque psoriasis: efficacy and safety results from 2 Japanese phase 3 trials","volume":"51","author":"Igarashi","year":"2024","journal-title":"J. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0365","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/j.jaad.2021.10.053","article-title":"A novel topical treatment for plaque psoriasis: Benvitimod\/tapinarof","volume":"86","author":"Zhang","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0370","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2133.2011.10438.x","article-title":"The mesenchymal stem cell profile in psoriasis","volume":"165","author":"Orciani","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0375","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/1346-8138.16490","article-title":"Normal mesenchymal stem cells can improve the abnormal function of T cells in psoriasis via upregulating transforming growth factor-\u03b2 receptor","volume":"49","author":"Jiao","year":"2022","journal-title":"J. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0380","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1684\/ejd.2021.4050","article-title":"Immunomodulatory effect of psoriasis-derived dermal mesenchymal stem cells on TH1\/TH17 cells","volume":"31","author":"Zhao","year":"2021","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0385","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-022-01059-y","article-title":"Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1\/2a, single-arm study","volume":"7","author":"Cheng","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.it.2025.01.002_bb0390","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/JIR.S397079","article-title":"Effects of neuropeptides on dendritic cells in the pathogenesis of psoriasis","volume":"16","author":"Zhang","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.it.2025.01.002_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106755","article-title":"A promising therapeutic target for psoriasis: neuropeptides in human skin","volume":"87","author":"Zhang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.it.2025.01.002_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2024.05.021","article-title":"Sensory neurons increase keratinocyte proliferation through CGRP release in a tissue engineered in vitro model of innervation in psoriasis","volume":"182","author":"Pepin","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.it.2025.01.002_bb0405","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/154411130201300303","article-title":"Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity","volume":"13","author":"Ganea","year":"2002","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0410","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.4049\/jimmunol.1801426","article-title":"Cholecystokinin downregulates psoriatic inflammation by its possible self-regulatory effect on epidermal keratinocytes","volume":"202","author":"Funakoshi","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0415","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jid.2017.08.015","article-title":"Lack of galanin receptor 3 alleviates psoriasis by altering vascularization, immune cell infiltration, and cytokine expression","volume":"138","author":"Sternberg","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0420","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10753-014-0064-2","article-title":"Inhibiting interleukin-18 production through the mitogen-activated protein kinase pathway, a potential role of corticotropin-releasing hormone in chronic plaque psoriasis","volume":"38","author":"Zhou","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.it.2025.01.002_bb0425","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/1061186X.2015.1103743","article-title":"Percutaneous delivery of \u03b1-melanocyte-stimulating hormone for the treatment of imiquimod-induced psoriasis","volume":"24","author":"Shah","year":"2016","journal-title":"J. Drug Target."},{"key":"10.1016\/j.it.2025.01.002_bb0430","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JCM.40.1.198-204.2002","article-title":"Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis","volume":"40","author":"Eishi","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.it.2025.01.002_bb0435","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1165\/rcmb.2015-0212OC","article-title":"Molecular analysis of sarcoidosis granulomas reveals antimicrobial targets","volume":"55","author":"Rotsinger","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.it.2025.01.002_bb0440","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/jamadermatol.2013.4646","article-title":"Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study","volume":"149","author":"Drake","year":"2013","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0445","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s10875-012-9817-6","article-title":"Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-\u03b3 expression","volume":"33","author":"Richmond","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0450","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10875-009-9311-y","article-title":"Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101","volume":"30","author":"Oswald-Richter","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0455","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.rmed.2016.10.003","article-title":"Smoking, obesity and risk of sarcoidosis: a population-based nested case\u2013control study","volume":"120","author":"Ungprasert","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0460","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.it.2025.01.002_bb0465","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/bbrc.1998.9599","article-title":"Nicotine inhibits the production of inflammatory mediators in U937 cells through modulation of nuclear factor-kappaB activation","volume":"252","author":"Sugano","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.it.2025.01.002_bb0470","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.chest.2021.05.031","article-title":"A pilot randomized trial of transdermal nicotine for pulmonary sarcoidosis","volume":"160","author":"Crouser","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.it.2025.01.002_bb0475","article-title":"The role of diverse immune cells in sarcoidosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0480","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","article-title":"Cancer stem cell mimicry for immune evasion and therapeutic resistance","volume":"31","author":"Saw","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.it.2025.01.002_bb0485","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.it.2025.01.002_bb0490","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3390\/jcm9041081","article-title":"Sarcoidosis: causes, diagnosis, clinical features, and treatments","volume":"9","author":"Jain","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0495","doi-asserted-by":"crossref","DOI":"10.1063\/5.0074317","article-title":"Appreciating the role of cell shape changes in the mechanobiology of epithelial tissues","volume":"3","author":"Luciano","year":"2022","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.it.2025.01.002_bb0500","doi-asserted-by":"crossref","first-page":"937","DOI":"10.20892\/j.issn.2095-3941.2020.0406","article-title":"Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy","volume":"18","author":"Gong","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0505","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.it.2025.01.002_bb0510","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1073\/pnas.0437899100","article-title":"Antigen presentation by keratinocytes directs autoimmune skin disease","volume":"100","author":"Fan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.01.002_bb0515","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/s12276-020-00489-4","article-title":"Pellino1 promotes chronic inflammatory skin disease via keratinocyte hyperproliferation and induction of the T helper 17 response","volume":"52","author":"Kim","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0520","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.md.0000157577.69729.e6","article-title":"Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases","volume":"84","author":"Ramos-Casals","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.it.2025.01.002_bb0525","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.chest.2018.03.056","article-title":"Drug-induced sarcoidosis-like reactions","volume":"154","author":"Chopra","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.it.2025.01.002_bb0530","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/joim.12991","article-title":"Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database","volume":"288","author":"Cohen Aubart","year":"2020","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0535","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2133.2004.06107.x","article-title":"Psoriatic lesions induced by antitumour necrosis factor-alpha treatment: two cases","volume":"151","author":"Dereure","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0540","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jaad.2016.08.012","article-title":"Tumor necrosis factor-\u03b1 inhibitor-induced psoriasis: systematic review of clinical features, histopathological findings, and management experience","volume":"76","author":"Brown","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0545","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jaad.2020.12.010","article-title":"Paradoxical eruptions to targeted therapies in dermatology: a systematic review and analysis","volume":"86","author":"Murphy","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0550","first-page":"336","article-title":"Paradoxical psoriasiform reactions to anti-TNF\u03b1 drugs are associated with genetic polymorphisms in patients with psoriasis","volume":"16","author":"Cabaleiro","year":"2016","journal-title":"Pharm. J."},{"key":"10.1016\/j.it.2025.01.002_bb0555","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jaad.2020.08.137","article-title":"Immune checkpoint-mediated psoriasis: a multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group","volume":"84","author":"Nikolaou","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0560","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.abd.2023.09.003","article-title":"Psoriasis de novo or exacerbation by PD-1 checkpoint inhibitors","volume":"99","author":"Wan","year":"2024","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0565","article-title":"A case of de novo psoriasis secondary to nivolumab in a patient with metastatic renal cell carcinoma","volume":"13","author":"Mullangi","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.it.2025.01.002_bb0570","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/cup.14185","article-title":"Severe de novo pustular psoriasiform immune-related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma","volume":"49","author":"Seervai","year":"2022","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.it.2025.01.002_bb0575","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2340\/00015555-2212","article-title":"Exacerbation of psoriasis during nivolumab therapy for metastatic melanoma","volume":"96","author":"Matsumura","year":"2016","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.it.2025.01.002_bb0580","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s12328-020-01134-3","article-title":"Exacerbation of psoriasis vulgaris by sorafenib treatment for hepatocellular carcinoma","volume":"13","author":"Adachi","year":"2020","journal-title":"Clin. J. Gastroenterol."},{"key":"10.1016\/j.it.2025.01.002_bb0585","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1127470","article-title":"Antigen-specificity measurements are the key to understanding T cell responses","volume":"14","author":"Tippalagama","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0590","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41392-023-01722-y","article-title":"Lung microbiome: new insights into the pathogenesis of respiratory diseases","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.it.2025.01.002_bb0595","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"Seve","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.it.2025.01.002_bb0600","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/bjd.17931","article-title":"Gut microbiota dysbiosis in a cohort of patients with psoriasis","volume":"181","author":"Hidalgo-Cantabrana","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1192543","article-title":"Advances in psoriasis and gut microorganisms with co-metabolites","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.it.2025.01.002_bb0610","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1378\/chest.109.2.535","article-title":"Vitamin D, calcium, and sarcoidosis","volume":"109","author":"Sharma","year":"1996","journal-title":"CHEST"},{"key":"10.1016\/j.it.2025.01.002_bb0615","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archderm.141.5.601","article-title":"Hormonal effect on psoriasis in pregnancy and post partum","volume":"141","author":"Murase","year":"2005","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0620","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.mayocpiqo.2019.04.006","article-title":"Clinical manifestations, diagnosis, and treatment of sarcoidosis","volume":"3","author":"Ungprasert","year":"2019","journal-title":"Mayo Clin. Proc. Innov. Qual. Outc."},{"key":"10.1016\/j.it.2025.01.002_bb0625","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0625.2010.01210.x","article-title":"Adipokines and psoriasis","volume":"20","author":"Gerdes","year":"2011","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0630","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fimmu.2014.00117","article-title":"The dopaminergic system in autoimmune diseases","volume":"5","author":"Pacheco","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.01.002_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2019.102004","article-title":"Neurotransmitters, neuropeptides and their receptors interact with immune response in healthy and psoriatic skin","volume":"79","author":"Sandoval-Talamantes","year":"2020","journal-title":"Neuropeptides"},{"key":"10.1016\/j.it.2025.01.002_bb0640","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2353\/ajpath.2007.061067","article-title":"The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis","volume":"171","author":"Mee","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.it.2025.01.002_bb0645","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jid.2017.12.029","article-title":"The genetics of chronic itch: gene expression in the skin of patients with atopic dermatitis and psoriasis with severe itch","volume":"138","author":"Nattkemper","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0650","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jid.2018.06.191","article-title":"Keratinocyte expression of A20\/TNFAIP3 controls skin inflammation associated with atopic dermatitis and psoriasis","volume":"139","author":"Devos","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0655","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.it.2025.01.002_bb0660","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1086\/377159","article-title":"The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs","volume":"73","author":"International Psoriasis Genetics Consortium","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.it.2025.01.002_bb0665","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.0022-202X.2004.23511.x","article-title":"The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis","volume":"124","author":"Allen","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0670","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1086\/503821","article-title":"Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene","volume":"78","author":"Nair","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.it.2025.01.002_bb0675","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1084\/jem.20151093","article-title":"Melanocyte antigen triggers autoimmunity in human psoriasis","volume":"212","author":"Arakawa","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0680","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jid.2016.04.033","article-title":"Binding affinity and interaction of LL-37 with HLA-C*06:02 in psoriasis","volume":"136","author":"Mabuchi","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0685","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1074\/mcp.M114.042242","article-title":"Proteomics of skin proteins in psoriasis: from discovery and verification in a mouse model to confirmation in humans","volume":"14","author":"Lundberg","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.it.2025.01.002_bb0690","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000104422","article-title":"Topo-proteomic in situ analysis of psoriatic plaque under efalizumab treatment","volume":"20","author":"Bonnekoh","year":"2007","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.it.2025.01.002_bb0695","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41598-020-57542-5","article-title":"Large-scale analyses of disease biomarkers and apremilast pharmacodynamic effects","volume":"10","author":"Medvedeva","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.it.2025.01.002_bb0700","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jprot.2013.09.010","article-title":"A proteomics approach to the identification of biomarkers for psoriasis utilising keratome biopsy","volume":"94","author":"Williamson","year":"2013","journal-title":"J. Proteome"},{"key":"10.1016\/j.it.2025.01.002_bb0705","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/PTT.S492205","article-title":"Unveiling novel protein biomarkers for psoriasis through integrated analysis of human plasma proteomics and mendelian randomization","volume":"14","author":"Mao","year":"2024","journal-title":"Psoriasis Target. Ther."},{"key":"10.1016\/j.it.2025.01.002_bb0710","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/all.12919","article-title":"Proteome analysis identifies L1CAM\/CD171 and DPP4\/CD26 as novel markers of human skin mast cells","volume":"72","author":"Gschwandtner","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.it.2025.01.002_bb0715","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.2147\/CCID.S433280","article-title":"Metabolomics reveals molecular signatures for psoriasis biomarkers and drug targets discovery","volume":"16","author":"Song","year":"2023","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.it.2025.01.002_bb0720","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fphar.2020.00117","article-title":"Pathogenesis of chronic plaque psoriasis and its intersection with cardio-metabolic comorbidities","volume":"11","author":"Gisondi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.it.2025.01.002_bb0725","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3390\/cells11091513","article-title":"Alpha-linolenic acid modulates T cell incorporation in a 3D tissue-engineered psoriatic skin model","volume":"11","author":"Morin","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.it.2025.01.002_bb0730","article-title":"TargetScore used to reveal potential targets of miRNA203 and miRNA-146a in psoriasis by integrating microRNA overexpression and microarray data","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.it.2025.01.002_bb0735","doi-asserted-by":"crossref","first-page":"D1398","DOI":"10.1093\/nar\/gkab953","article-title":"Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents","volume":"50","author":"Zhou","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.it.2025.01.002_bb0740","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.3892\/mmr.2016.4999","article-title":"PageRank analysis reveals topologically expressed genes correspond to psoriasis and their functions are associated with apoptosis resistance","volume":"13","author":"Zeng","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.it.2025.01.002_bb0745","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2340\/00015555-2595","article-title":"Opioid receptors in psoriatic skin: relationship with itch","volume":"97","author":"Kupczyk","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.it.2025.01.002_bb0750","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MCP.0000000000000403","article-title":"Transcriptome profiles in sarcoidosis and their potential role in disease prediction","volume":"23","author":"Schupp","year":"2017","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.it.2025.01.002_bb0755","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1165\/rcmb.2017-0207OC","article-title":"A circulating microRNA signature serves as a diagnostic and prognostic indicator in sarcoidosis","volume":"58","author":"Ascoli","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.it.2025.01.002_bb0760","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12881-016-0266-6","article-title":"Altered miRNA expression in pulmonary sarcoidosis","volume":"17","author":"Kisza\u0142kiewicz","year":"2016","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.it.2025.01.002_bb0765","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11306-015-0932-2","article-title":"Metabolomics connects aberrant bioenergetic, transmethylation, and gut microbiota in sarcoidosis","volume":"12","author":"Geamanu","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.it.2025.01.002_bb0770","doi-asserted-by":"crossref","first-page":"19584","DOI":"10.1038\/s41598-019-56174-8","article-title":"Metabolomic and metallomic profile differences between veterans and civilians with pulmonary sarcoidosis","volume":"9","author":"Banoei","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149062500002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149062500002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:51:43Z","timestamp":1778615503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149062500002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":154,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S147149062500002X"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2025.01.002","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u2018inflammazone\u2019 in chronic inflammatory diseases: psoriasis and sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2025.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}